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ABSTRACT U937 is a human-derived lymphoma cell line that
has monoblastic properties and high-affinity receptors for la,-
dihydroxyvitamin D3. Incubation of these cells with the vitamin
D metabolite at 10 nM for 5 days produced marked stimulation
in adherence and ingestion of Staphylococcus aureus (645% of
control) and of C3b receptor (CR1) expression (292% of control)
and a slight increase in hexose monophosphate shunt activity with-
out changing cell growth rates or Fc fragment receptor expres-
sion. The changes in cellular association of S. aureus and the CR1
were detected as early as 48 hr of incubation and peaked between
3 and 5 days. Similar changes in the CR1 were induced by 25-hy-
droxy- and 24,25-dihydroxyvitamin D3 at micromolar concentra-
tions. Dexamethasone, hydrocortisone, and progesterone had no
effect on CR1 expression. U937 cells incubated in the presence of
vitamin D metabolites exhibited a change in their phenotype. These
results suggest that vitamin D metabolites may contribute to
monocyte/macrophage differentiation.
The most active metabolite of vitamin D, la,25-dihydroxyvi-
tamin D3 [la,25(OH)2D3], produces its biological effect on cells
through binding to a cytoplasmic receptor (1). Receptors with
high affinity for la,25(OH)2D3 have been described in the es-
tablished target organs for vitamin D-i.e., small intestine,
skeleton, and kidneys (2). Recently, cellular receptors for
la,25(OH)2D3 have been reported to occur in other tissues and
some tumor cell lines, suggesting a role for this metabolite that
had not been appreciated previously (2). Cells from the HL-60
and M-1 lines, tumor cells of hematopoietic origin, differen-
tiated into more mature cells when incubated with vitamin D
metabolites (3, 4). Another tumor cell line, the U937 cell, con-
tains a cytoplasmic receptor with high affinity for 1a,25(0H)2D3
(5). The U937 cell line is of human origin and has monoblastic
characteristics (6). It is known to differentiate into a macro-
phage-like cell when incubated with retinoic acid (7, 8), lym-
phokines (9-11), or phorbol esters (12, 13). Therefore, it ap-
pears to be an attractive model for studying the effects of vitamin
D metabolites on macrophages and their precursors. This re-
port describes the phenotypic changes induced by several vi-
tamin D metabolites, including la,25(0H)2D3 and 24,25-dihy-
droxy- and 25-hydroxyvitamin D3 [24,25(0H)2D3 and 25(OH)D3,
respectively] on U937 cells.
MATERIALS AND METHODS
Vitamin D3 Derivatives and Hormones. la,25(0H)2D3 and
24,25(OH)2D3 were provided by M. Uskokovic (Hoffman-
LaRoche). 25(OH)D3 was a gift from Upjohn. Dexamethasone
was purchased from Elkins-Sinn (Cherry Hill, NJ); 17-hydroxy-
hydrocortisone was from Mann Research Laboratories (New
York); and progesterone was from Nutritional Biochemicals.
Purity of the vitamin D compounds was confirmed by high
pressure liquid chromatography.
Cells and Cell Culture Conditions. U937 cells were passaged
every 2 to 3 days in medium consisting of Dulbecco's modified
Eagle's minimal essential medium (GIBCO)/Ham's F-12 me-
dium (GIBCO) (1:1) supplemented with 10% fetal bovine serum
(GIBCO), 15 mM Hepes, penicillin at 100 units/ml, and strep-
tomycin at 100 ,ug/ml. In experiments to determine expression
of the C3b receptor, 5% fetal bovine serum was added to the
medium. Cells were incubated at 370C in humidified 5% C02/
95% air.
For each experiment, 106 cells were placed in 10 ml of me-
dium in a plastic 100-mm Petri dish (Corning) and 10 1.d of the
specified vitamin D solution or vehicle (ethanol) was added to
each dish. Cells cultured for longer than 72 hr were centrifuged
at 120 X g for 10 min and resuspended in 10 ml of fresh me-
dium, and the original concentration of additive was restored.
At the time of each experiment, the cells were centrifuged at
120 x g for 10 min and resuspended in fresh medium to the
desired concentration. A radioimmunoassay (14) of the culture
medium showed the la,25(OH)2D3 concentration to be 10 pM.
To evaluate growth rates, 106 cells were placed in 10 ml of
medium and counted by hemocytometer after 5 days of in-
cubation. Viability was determined by trypan blue exclusion
and was found to be 98% for all experiments. Morphology was
assessed by phase-contrast microscopy.
Measurement of Cellular Association of Opsonized Staph-
ylococcus aureus. 14C-Labeled heat-killed S. aureus were pre-
pared according to the methods of Root et al. (15). U937 cells
were incubated for 5 days with various concentrations of
la,25(OH)2D3; 2.0 X 106 cells in 0.9 ml of culture medium were
added to 0.1 ml of pooled human serum and 2.1 x 107 14C-la-
beled S. aureus and placed in 12 x 75 mm glass tubes. From
each Petri dish, two of these samples were placed on ice as 0
time controls and two samples were incubated for 120 min at
37°C in a rotator. After the 120 min, 2 ml of cold Hanks' bal-
anced salt solution (HBSS) 10% fetal bovine serum/2 mM NaF
was added to each tube and the mixtures were centrifuged at
35 X g for 5 min at 4°C. The cell pellet was washed twice with
4 ml of the above solution and incubated overnight in 0.5 ml
of 0.5 M NaOH to lyse the cells. Then, 0.2 ml of 3% acetic acid
and 0.5 ml of normal saline were added to the tubes, the entire
mixtures were added to 10 ml of Aquasol (New England Nu-
clear), and radioactivity was counted for 10 min in an LS2000
(Beckman Instruments). This assay detects the number of cell-
Abbreviations: la,25(OH)2D3, 24,25(OH)2D3, and 25(OH)D3, la,25-
dihydroxy, 24,25-dihydroxy-, and 25-hydroxyvitamin D3, respectively;
CR1 and CR3, type 1 complement receptor and C3bi receptor; HBSS,
Hanks' balanced salt solution; PMA, phorbol 12-myristate 13-acetate.
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Table 1. Cellular association of 14C-labeled S. aureus with U937
cells incubated for 5 days with la,25(OH)2D3
0-min 120-min
la,25(0H)2DA, nM incubation incubation % control
0.01* (control) 244 ± 59 689 ± 105 100
1 231 ± 61 1,669 ± 244t 242
10 239 ± 91 4,443 ± 255t 645
Results represent mean ± SDof '4C radioactivity. Each experiment
was done in triplicate and each determination was done in duplicate.
*nAmount of la,25(OH)ID3 present in the standard culture medium. Its
source is the fetal bovine serum; 2 x 107 bacteria had 15,700 cpm. A
particle/cell ratio of 20:1 was used.
tP < 0.01 vs. control by analysis of variance using the Fischer least
significant difference test.
associated Staphylococcus but does not allow distinction of at-
tachment from ingestion.
Detection of CRI and Fc Receptors. The type 1 comple-
ment receptor (CR1) and the C3bi receptor (CR3) were detected
by using sheep erythrocytes (E) coated with C3b (EC3b) or C3bi
(EC3bi) prepared according to the method of Ross et al. (16).
From each Petri dish, 5 x 105 U937 cells in 0.1 ml of fresh
medium were incubated with 0.1 ml of HBSS/0.25% bovine
serum albumin containing 2 x 107 coated sheep erythrocytes
in 10 x 75 mm plastic tubes at 37C for 30 min while being
gently rotated. An aliquot was removed, placed on a micro-
scope slide, and sealed under a coverslip; rosettes were counted
by phase-contrast microscopy. A rosette was defined as a cell
with three or more erythrocytes attached. A total of 200 cells
from each sample was counted.
Rabbits were immunized with CR1 antigen and IgG antibody
isolated from the rabbit serum by DEAE chromatography and
50%o ammonium sulfate precipitation as described (17-19). F(ab')2
fragments of anti-CR1 were prepared by pepsin digestion and
chromatography on Sephadex G-150 (19).
The presence of Fc receptors was detected with a fluores-
cence technique (20). Cells cultured for 5 days in 10 nM
la,25(OH)2D3 or vehicle were then suspended in HBSS/2%
bovine serum albumin/0.02% NaN3 at 1 X 107/ml. A 25-id
aliquot was incubated with 25 Al of aggregated IgG at 4TC for
30 min and then centrifuged at 120 x g for 10 min at 40C. The
supernatant was removed and 25 Al of fluorescein isothiocy-
anate-labeled goat F(ab')2 anti-IgG was added to each cell pellet
and incubated at 4TC for 30 min. The cell mixture was then lay-
ered on 2 ml of phosphate-buffered saline/6% bovine serum
albumin/0.2% NaN3 and centrifuged at 250 x g at 4TC for 5
min. The supernatant was discarded and the cells on the bottom
were aspirated and placed on a slide, sealed under a coverslip,
and examined under a fluorescence microscope. The percent-
age of cells exhibiting fluorescent particles per 200 cells was
reported.
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Hexose Monophosphate Shunt Activity. U937 cells cultured
with 10 nM la,25(OH)2D3 or vehicle for 5 days were harvested
and resuspended at 15 x 106/ml. A 0.5-ml aliquot of this sus-
pension was added to 0.5 ml of HBSS and 0.5 ml of [1-'4C]glu-
cose at ,C/ml (1 Ci = 37 GBq). Phorbol 12-myristate 13-ace-
tate (PMA) (100 ng/ml) was added to stimulate glucose utilization.
KCN (100 nM) was included to inhibit the mitochondrial me-
tabolism of glucose. A well containing 10% KOH absorbed the
'4C02 given off by oxidation of the glucose during the 120-min
incubation. At the end of the incubation, 0.5 ml of 1 M HCl
was added to each flask and the mixture was incubated for 15
min. The KOH-containing wells were then removed from the
stoppered flasks and placed in 10 ml of Aquasol plus 1.0 ml
H20, and radioactivity was counted for 10 min.
Superoxide Anion Production. U937 cells cultured with 10
nM la,25(0H)2D3 or vehicle for 5 days were washed and re-
suspended in HBSS at 5 x 106/ml. Ferrous cytochrome c (80
m) and PMA (100 ng/ml) were added to 0.5 ml of this cell sus-
pension. The total volume was brought to 1.0 ml with HBSS.
Three hundred units of superoxide dismutase was added to one
flask from each experiment. All experiments were done in du-
plicate. Flasks were incubated for 0, 60, and 120 min. After in-
cubation, the cells were centrifuged at 1,200 x g for 15 min and
the supernatants were removed to clean tubes. The ODW0 was
determined against a distilled water blank in a spectrophotome-
ter.
RESULTS
Effects of Vitamin D Derivatives on Cell Growth and Mor-
phology. U937 cells doubled in number by 36-48 hr. Cells were
cultured with vehicle, 0.1-10 nM la,25(OH)2D3, 0.01-1 AM
25(0H)D3, and 0.01-1 AM 24,25(OH)2D3. No differences in
growth rates were observed with these metabolites of vitamin
D compared with those with vehicle alone. Cells incubated with
1-10 nM 1,25(OH)2D3 exhibited increased clumping and sur-
face adherence compared with those incubated with vehicle.
This effect was mild and peaked between 3 and 5 days.
Effect of Vitamin D Derivatives on Phagocytic Activity. Ta-
ble 1 shows that attachment and ingestion of labeled S. aureus
by U937 cells cultured in the presence of la,25(OH)2D3 in-
creased in a dose-dependent manner. This increased activity
was seen as early as 48 hr but did not peak until 4 days (data
not shown). In a separate experiment, the effects of
la,25(0H)2D3, 25(OH)D3, and 24,25(OH)2D3 were compared
after 5 days of incubation (Table 2). At 10 nM, only 1,25(OH)2D3
was capable of stimulating the cellular association of S. aureus
particles.
Effects of Vitamin D Compounds on CR1 and Fc Receptors.
Culture of U937 cells with la,25(0H)2D3 for 5 days signifi-
cantly increased the number of cells expressing CR1 (Table 3).
This response was dose and time dependent. CR1 expression
Table 2. Effects of incubation of U937 cells for 5 days with 25(OH)D3 or 24,25(OH)2D3 on cellular
association of 14C-labeled S. aureus
cpm
0-min 120-min %
Vitamin D metabolite Conc., nM incubation incubation control
la,25(OH)2D3 (control) 0.01* 279 ± 97 (2) 1,162 ± 87 (2) 100
25(OH)D3 10 194 ± 41 (3) 1,237 ± 87 (3) 106
24,25(OH)2D3 10 231 ± 44 (3) 1,073 ± 135 (3) 92
la,25(OH)2D3 10 230 ± 60 (2) 5,638 ± 439 (2)t 485
Results represent mean ± SD of 14C radioactivity for the number of experiments indicated in paren-
theses. Each determination was done in triplicate.
*Amount of 1a,25(OH)2D3 present in the standard culture medium. Its source is the fetal bovine serum.
tP < 0.01 vs. control.
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Table 3. Stimulation of CR1 formation by 1a,25(0H)2D3 after 5
days of incubation
la,25(OH)2D3, nM % rosettes
0.01 (control) 14 ± 3 (6)
1 30 ± 4 (9)*
10 36 ± 5(9)t
Results represent mean ± SEM for the number of experiments in-
dicated in parentheses.
*P < 0.05 vs. control.tP < 0.01 vs. control.
was not increased after 24 hr of culture with 10 nM
1a,24(0H)2D3; however, by 48 hr, there was a three-fold rise
above controls (16% vs. 46%) in the percentage of cells ex-
pressing CR1. This increase persisted for at least 5 days. Cell
incubation for 5 days with dexamethasone, hydrocortisone, or
progesterone did not increase the percentage of cells express-
ing CR1 (Table 4).
In separate experiments, the effects of 24,25(0H)2D3 and
25(OH)D3 on CR1 expression were compared with the la,25-
(OH)2D3-induced effects and controls (Table 5). At 1 /uM, both
24,25(OH)2D3 and 25(OH)D3 significantly increased CR1 ex-
pression, but the effect was less than that of treatment with 10
nM la,25(0H)2D3.
Cells cultured for 5 days with 10 nM la,25(0H)2D3 or ve-
hicle alone formed no rosettes with either erythrocytes alone
or EC3bi (specific for CR3 under the assay conditions used). In
addition, prior incubation of U937 cells with 43 tug of F(ab')2
anti-CR1 completely abolished rosette formation with EC3b.
Fc receptors were present on 35% of the control cells. Cul-
ture of U937 cells with 1-10 nM la,25(0H)2D3 for 5 days did
not significantly change the percentage of Fc receptor-positive
cells (data not shown).
Effects of Vitamin D on Hexose Monophosphate Shunt Ac-
tivity and Superoxide Anion Production. Hexose monophos-
phate shunt activity was measured after culture of U937 cells
with either 10 nM 1a,25(0H)2D3 or vehicle alone. Resting cells
(no PMA added) were compared with PMA-stimulated cells after
a 120-min incubation with [1-"C]glucose. Results of two rep-
resentative experiments are shown in Table 6. Total production
of 1'CO2 was greater in both PMA-stimulated and resting cells
incubated with 10 nM la,25(0H)2D3 compared with vehicle
alone. However, the amount of stimulation over resting levels
was not enhanced by incubation of the U937 cells with
1a,25(0H)2D3.
Superoxide anion production by resting and PMA-stimulated
cells cultured with 10 nM la,25(OH)2D3 for 5 days was not dif-
ferent than control (data not shown).
DISCUSSION
The monoblastic human cell line designated U937 was induced
by three naturally occurring metabolites of vitamin D to change
its phenotype. The ability of vitamin D to differentiate he-
Table 4. Specificity of la,25(OH)ADs for CR1 expression
Steroid Conc., nM % rosettes
la,25(OH)2D3 (control) 0.01 16.0 ± 1
Progesterone 1,000 14.0 ± 3
Hydrocortisone 1,000 6.0 ± 1*
Dexamethasone 1,000 4.0 ± 1*
la,25(OH)2D3 10 34.0 ± 1*
Cells were incubated for 5 days with various steroids. Results rep-
resent mean ± SEM. Each experiment was done four times.
*P < 0.05 vs. control.
Table 5. Stimulation of CR1 expression by 25(OH)D3 and
24,25(OH)2D3 after 5 days of incubation
Vitamin D metabolite Conc., nM % rosettes
la,25(OH)2D3 (control) 0.01 14 ± 1 (12)
25(OH)D3 10 15 ± 3 (10)
1,000 25 ± 2 (10)*
24,25(OH)2D3 10 14 ± 2 (10)
1,000 31 ±5 (10)*
la,25(OH)2D3 10 38 ± 4 (12)*
Results represent mean ± SEM for the number of experiments in-
dicated in parentheses.
*P < 0.01 vs. control.
matopoietic cell lines has recently been reported (3, 4). In those
studies, vitamin D metabolites induced differentiation of the
HL-60 and M-I myeloid leukemia cell lines as evidenced by
changes in morphology, phagocytosis, and C3b receptor (CR1)
formation. As the concentration of la,25(OH)2D3 was in-
creased from 10 pM to 10 nM, we observed dose-dependent
increases in the cellular association of S. aureus particles (Table
1) and in the number of cells that expressed CR1 (Table 3) and
minor changes in both hexose monophosphate shunt activity
and cell morphology in U937 cells cultured for 5 days. These
changes were not limited to la,25(OH)2D3. Increases in the
percentage of cells expressing CR1 were observed when U937
cells were cultured with 24,25(OH)D3 and 25(OH)D3. The lat-
ter metabolites produced these effects at concentrations higher
than la,25(OH)2D3 (1 AM vs. 10 nM). Furthermore, the re-
sponse to these two metabolites at 1 ,M was less than the re-
sponse associated with 10 nM la,25(OH)2D3.
The ability of three vitamin D metabolites to induce differ-
entiation in U937 cells correlated well with their affinity for the
1,25(OH)2D3 cytoplasmic receptor. This has been found to be
true in the M-1 (4) and the HL-60 (21) cell-line. On a molar
basis, la,25(OH)2D3 was the most potent of the naturally oc-
curring vitamin D derivatives in each report. Suda et al. (21)
have shown that, in the HL-60 line, 10 nM la,25(OH)2D3, 0.1
,M 25(OH)D3, and 1 ,M 24R,25(OH)2D3 all produce equal
stimulation of phagocytosis and CR1 expression after 3 days of
incubation. The normal physiologic levels of la,25(OH)2D3,
24,25(OH)2D3, and 25(OH)D3 are 0. 1 nM, 10 nM, and 0.1 ,u M,
respectively (22). Thus, when one considers the differences in
the physiologic concentrations of these three metabolites,
la,25(OH)2D3 25(OH)D3, and 24,25(OH)2D3 were comparable
in their ability to induce differentiation. This suggests that in-
duction is not a unique effect of la,25(OH)2D3. However, the
in vitro concentrations of the vitamin D metabolites associated
with phenotypic changes in this study and in the reports from




la,25(OH)2D3, nm (no PMA added) stimulated
Experiment A
0.01 (control) 2,424 (1) 2,972 ± 77 (5)
10 2,565 (1) 3,394 ± 48 (5)*
Experiment B
0.01 (control) 2,380 (1) 3,470 ± 200 (5)
10 2,975 (1) 4,114 + 183 (5)*
PMA-stimulated and resting cells were incubated with [1-_4C]glu-
cose at 370C for 120 min. Results represent mean ± SEM for the num-
ber of experiments indicated in parentheses.
*P < 0.05 vs. PMA-stimulated controls.
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other laboratories (3, 4, 21) were higher than the physiological
levels.
Dexamethasone (1 ,uM) induced differentiation in the M-1
cell line (23), suggesting that steroids other than vitamin D may
influence maturation. However, culture of U937 cells with
dexamethasone, hydrocortisone, or progesterone failed to in-
crease the expression of CR1 (Table 4). Dexamethasone at 1 ,uM
decreased cell number while hydrocortisone had no effect on
cell growth.
The induction of U937 differentiation by retinoic acid has
been reported recently (7, 8). The differentiation induced by
this agent was associated with a reduction in cellular growth.
In contrast, incubation with the three vitamin D metabolites
did not alter the growth rate of U937 cells. Koren et al. (9) have
shown that conditioned medium from human mixed lympho-
cyte cultures activates U937 cells and increases Fc receptors as
well as antibody-dependent cellular cytotoxicity against eryth-
roid and tumor target cells. In our studies, la,25(OH)2D3 did
not change Fc receptor expression. This difference implies that
vitamin D metabolites affect U937 cells via a different mech-
anism than lymphokines. Olsson and Breitman (7) found that
U937 cells incubated with retinoic acid showed increased re-
duction of nitroblue tetrazolium and increased hexose mono-
phosphate shunt activity. In our study, hexose monophosphate
shunt activity was not increased when cells were stimulated with
PMA. The difference in these two reports may be due to dif-
ferences in the action of vitamin D metabolites and retinoic acid
or secondary to the differences in experimental conditions and
techniques. To date, no agent, including la,25(OH)2D3, has
been reported to induce phenotypic expression consistent with
a fully mature macrophage.
A recent report that cultured U937 cells had virtually no su-
peroxide anion production unless stimulated by lymphokines
(24) is consistent with our results and further supports the the-
ory that vitamin D metabolites and lymphokines act on U937
cells by different pathways.
The mechanisms by which vitamin D metabolites and reti-
noic acid induce differentiation are unknown. Studies of the
murine erythroleukemia line suggest that intracellular calcium
ion concentration or fluxes may be important in the commit-
ment for differentiation (25, 26). Increases in calcium mem-
brane permeability and changes in the lipid composition of the
cell membrane have been shown to occur as a result of ex-
posure to la,25(OH)2D3 (27). It is also possible that vitamin D
metabolites induce formation of new membrane proteins re-
sponsible for altering calcium transport. The 24- to 48-hr in-
cubation required before increased S. aureus association and
CR1 formation can be detected in U937 cells indicates that the
formation of cellular products may be required for the expres-
sion of differentiation.
In summary, this study showed that the presence of
la,25(OH)2D3 receptors in the U937 cell line is associated with
a functional response. These findings are consistent with the
hypothesis that vitamin D metabolites play a role in the process
of stem cell and monocyte/macrophage differentiation.
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